| Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer S Bullman, CS Pedamallu, E Sicinska, TE Clancy, X Zhang, D Cai, ... Science 358 (6369), 1443-1448, 2017 | 1257 | 2017 |
| Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer M Scaltriti, F Rojo, A Ocaña, J Anido, M Guzman, J Cortes, S Di Cosimo, ... Journal of the National Cancer Institute 99 (8), 628-638, 2007 | 1068 | 2007 |
| Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma L De Mattos-Arruda, R Mayor, CKY Ng, B Weigelt, F Martínez-Ricarte, ... Nature communications 6 (1), 8839, 2015 | 759 | 2015 |
| Dose-and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors J Tabernero, F Rojo, E Calvo, H Burris, I Judson, K Hazell, E Martinelli, ... Journal of Clinical Oncology 26 (10), 1603-1610, 2008 | 654 | 2008 |
| p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors C Romagosa, S Simonetti, L Lopez-Vicente, A Mazo, ME Lleonart, ... Oncogene 30 (18), 2087-2097, 2011 | 633 | 2011 |
| Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor C Sánchez, ML de Ceballos, TG del Pulgar, D Rueda, C Corbacho, ... Cancer research 61 (15), 5784-5789, 2001 | 572 | 2001 |
| Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity M Scaltriti, C Verma, M Guzman, J Jimenez, JL Parra, K Pedersen, ... Oncogene 28 (6), 803-814, 2009 | 501 | 2009 |
| β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer SP Tenbaum, P Ordóñez-Morán, I Puig, I Chicote, O Arqués, S Landolfi, ... Nature medicine 18 (6), 892-901, 2012 | 433 | 2012 |
| Clinical implications of intratumor heterogeneity: challenges and opportunities S Ramón y Cajal, M Sesé, C Capdevila, T Aasen, L De Mattos-Arruda, ... Journal of Molecular Medicine 98, 161-177, 2020 | 358 | 2020 |
| STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis N Priego, L Zhu, C Monteiro, M Mulders, D Wasilewski, W Bindeman, ... Nature Medicine 24 (7), 1024-1035, 2018 | 355 | 2018 |
| Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM JG Viniegra, N Martínez, P Modirassari, JH Losa, CP Cobo, VJSA Lobo, ... Journal of Biological Chemistry 280 (6), 4029-4036, 2005 | 353 | 2005 |
| 4E-binding protein 1: a key molecular “funnel factor” in human cancer with clinical implications G Armengol, F Rojo, J Castellví, C Iglesias, M Cuatrecasas, B Pons, ... Cancer research 67 (16), 7551-7555, 2007 | 337 | 2007 |
| 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis F Rojo, L Najera, J Lirola, J Jimenez, M Guzman, MD Sabadell, J Baselga, ... Clinical Cancer Research 13 (1), 81-89, 2007 | 265 | 2007 |
| Role of the p38 MAPK pathway in cisplatin-based therapy JH Losa, CP Cobo, JG Viniegra, VJSA Lobo, R Sanchez-Prieto Oncogene 22 (26), 3998-4006, 2003 | 229 | 2003 |
| A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis K Pedersen, PD Angelini, S Laos, A Bach-Faig, MP Cunningham, ... Molecular and cellular biology 29 (12), 3319-3331, 2009 | 222 | 2009 |
| Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer J Castellvi, A Garcia, F Rojo, C Ruiz‐Marcellan, A Gil, J Baselga, ... Cancer 107 (8), 1801-1811, 2006 | 218 | 2006 |
| HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome T Cuadros, E Trilla, E Sarro, MR Vila, J Vilardell, I de Torres, M Salcedo, ... Cancer research 74 (5), 1416-1428, 2014 | 194 | 2014 |
| miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9 A Feliciano, J Castellvi, A Artero-Castro, JA Leal, C Romagosa, ... PloS one 8 (10), e76247, 2013 | 178 | 2013 |
| Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cerebrospinal fluid F Martínez-Ricarte, R Mayor, E Martínez-Sáez, C Rubio-Pérez, E Pineda, ... Clinical Cancer Research 24 (12), 2812-2819, 2018 | 171 | 2018 |
| Pharmacodynamic studies of gefitinib in tumor biopsy specimens from patients with advanced gastric carcinoma F Rojo, J Tabernero, J Albanell, E Van Cutsem, A Ohtsu, T Doi, W Koizumi, ... Journal of clinical oncology 24 (26), 4309-4316, 2006 | 170 | 2006 |
